UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 14A
(Rule 14a-101)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ | Preliminary Proxy Statement | |
☐ | Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
☐ | Definitive Proxy Statement | |
☒ | Definitive Additional Materials | |
☐ | Soliciting Material Under Rule Pursuant to § 240.14a-12 |
SURMODICS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒ | No fee required. | |||
☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
1) | Title of each class of securities to which transaction applies:
| |||
2) | Aggregate number of securities to which transaction applies:
| |||
3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
| |||
4) | Proposed maximum aggregate value of transaction:
| |||
5) | Total fee paid:
| |||
☐ | Fee paid previously with preliminary materials: | |||
☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing. | |||
1) | Amount previously paid:
| |||
2) | Form, Schedule or Registration Statement No.:
| |||
3) | Filing Party:
| |||
4) | Date Filed:
|
*** Exercise Your Right to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Shareholder Meeting to Be Held on February 13, 2019.
Before You Vote How to Access the Proxy Materials
| ||
Proxy Materials Available to VIEW or RECEIVE: | ||
NOTICE AND PROXY STATEMENT/10-K
| ||
How to View Online: | ||
Have the information that is printed in the box marked by the arrow (located on the following page) and visit: www.proxyvote.com.
| ||
How to Request and Receive a PAPER or E-MAIL Copy:
| ||
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request: | ||
1) BY INTERNET: www.proxyvote.com | ||
2) BY TELEPHONE: 1-800-579-1639 | ||
3) BY E-MAIL*: sendmaterial@proxyvote.com | ||
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow (located on the following page) in the subject line. | ||
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before January 30, 2019 to facilitate timely delivery.
| ||
|
How To Vote Please Choose One of the Following Voting Methods
| |
Vote By Internet:
Before The Meeting: Go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow (located on the following page) available and follow the instructions.
During The Meeting:
Go to www.virtualshareholdermeeting.com/SRDX19. Have the information that is printed in the box marked by the arrow (located on the following page) available and follow the instructions. | ||
Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
|
Voting Items | ||||
The Board of Directors recommends you vote FOR the following:
1. Election of Directors
Nominees:
01) Ronald B. Kalich 02) Shawn T McCormick | ||||
The Board of Directors recommends you vote FOR the following proposals:
2. Set the number of directors at seven (7);
3. Ratify the appointment of Deloitte & Touche LLP as Surmodics independent registered public accounting firm for fiscal year 2019;
4. Approve, in a non-binding advisory vote, the Companys executive compensation; and
5. Approve the Surmodics, Inc. 2019 Equity Incentive Plan.
NOTE: To consider and act upon such other matters as may properly come before the meeting or any adjournment or postponement of the meeting. | ||||
| ||
| ||